Nuveen’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-16,400
Closed -$5K – 3215
2019
Q4
$5K Buy
+16,400
New +$4.51M ﹤0.01% 3190

Other funds holding ELV

Nuveen's ELV Position: Q3 2026 in Review

Nuveen increased its Elevance Health (ELV) stake by 53% in Q3 2026, buying an estimated $423M and bringing the position to 3,051,056 shares worth $1.19B. The position accounts for 0.28% of the portfolio, ranked #63.

Nuveen first reported a position in ELV in Q2 2013 and has held it in 54 quarters since. The position peaked at $1.61B in Q4 2022. 1,629 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Nuveen held 3,051,056 shares of Elevance Health worth $1.19B as of Q3 2026.
  • Nuveen bought 1,061,193 Elevance Health shares in Q3 2026, an estimated $423M.
  • Elevance Health made up 0.28% of Nuveen's portfolio in Q3 2026, its #63 holding.
  • Nuveen first reported a position in Elevance Health in Q2 2013 and has held it in 54 quarters since.
  • Nuveen's Elevance Health position peaked at $1.61B in Q4 2022.
  • 1,629 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.